Clinical Trials Logo

Clinical Trial Summary

This study consists in a prospective pilot study evaluating the feasibility and safety of OTC RATS lobectomies in patients treated for lung cancer. All patients with clinical stage I tumors (≤cT2N0M0) planned to undergo a VATS or RATS lobectomy at the CHUM will be approached. At our institution, lobectomies are either performed open by thoracotomy or by MIS, including VATS and RATS. The technique is selected based on tumor size, tumor location and patient characteristics. Only patients already planned for a VATS or RATS lobectomy will be approached. They will be identified through the operation request forms and will be approached either in the preoperative clinic or the day before surgery, when admitted. The investigators aim to recruit 20 patients.


Clinical Trial Description

Consenting patients will undergo lobectomy by OTC RATS following the exact standard steps usually done by VATS/RATS, aside from the ports that will be placed in the subcostal plane. The characteristics of both the patient and the case, will determine the number of incisions from 1-4. The Davinci Xi® surgical system will be used to perform the lobectomy through the ports using the standard technique with an anterior approach. Once the procedure is completed, the robotic arms and ports will be removed from the chest and figure-of-8 stitches with non absorbable sutures will be placed to close the diaphragm at the site of insertion. A 24 Fr soft chest tube will be left in place, as in the standard VATS/RATS lobectomy procedure. The incision closure will be done in a standard manner. Enrolled patients will receive standard postoperative care. Chest tube removal and discharge will be decided by the treating surgeon, following the same criteria as VATS/RATS lobectomies. Images and videos will be recorded during the procedure. The postoperative course will be monitored in case of potential complications up to the 30-day follow-up appointment. Medical records will be verified to obtain postoperative outcomes at follow-up appointments at the surgical clinic. All data pertaining to the 1-year follow-up will be collected and analysed retrospectively. Chronic pain of OTC RATS lobectomy patients will be compared to that of VATS lobectomy patients, for which the data will also be collected and analysed retrospectively. A propensity match score will be conducted using the two groups of patients, divided by surgical approach, to adequately interpret the degree of chronic pain experienced by patients who have received surgery using an OTC approach versus the current minimally invasive thoracic approach. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05832112
Study type Interventional
Source Centre hospitalier de l'Université de Montréal (CHUM)
Contact
Status Active, not recruiting
Phase N/A
Start date February 22, 2023
Completion date June 9, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04375566 - Progressive Web App About Individualized Patient Decision Aid for NSCLC Stage I-II
Not yet recruiting NCT06060964 - Enabling Remote Access to Breathe Easier: A Novel Approach to Improve Symptom Management Early Phase 1
Active, not recruiting NCT03322072 - Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating N/A
Recruiting NCT06424327 - A Registry for People With Lung Cancer
Recruiting NCT03290534 - Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet® Phase 2
Recruiting NCT05281237 - Avecure Flexible Microwave Ablation Probe For Lung Nodules N/A
Recruiting NCT06432972 - Accelerated Pulmonary Rehabilitation in the Preoperative Period N/A
Terminated NCT03984019 - Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung Metastasis N/A
Recruiting NCT04125979 - Clinical Evaluation of Vagal Nerve Preservation in Minimally Invasive Surgery for Early Lung Cancer N/A
Recruiting NCT06016881 - Postoperative Chronic Operation-related Symptoms After Minimally Invasive Lung Surgery
Recruiting NCT04944173 - SCION: SABR and Checkpoint Inhibition Of NSCLC Phase 2